Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA; QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Mol Ther. 2021 Nov 3;29(11):3219-3229. doi: 10.1016/j.ymthe.2021.06.021. Epub 2021 Jul 2.
Alpha-1 antitrypsin deficiency (AATD) is most commonly caused by the Z mutation, a single-base substitution that leads to AAT protein misfolding and associated liver and lung disease. In this study, we apply adenine base editors to correct the Z mutation in patient induced pluripotent stem cells (iPSCs) and iPSC-derived hepatocytes (iHeps). We demonstrate that correction of the Z mutation in patient iPSCs reduces aberrant AAT accumulation and increases its secretion. Adenine base editing (ABE) of differentiated iHeps decreases ER stress in edited cells, as demonstrated by single-cell RNA sequencing. We find ABE to be highly efficient in iPSCs and do not identify off-target genomic mutations by whole-genome sequencing. These results reveal the feasibility and utility of base editing to correct the Z mutation in AATD patient cells.
α-1 抗胰蛋白酶缺乏症(AATD)最常见的原因是 Z 突变,这是一种导致 AAT 蛋白错误折叠和相关肝肺疾病的单碱基替换。在这项研究中,我们应用腺嘌呤碱基编辑器纠正患者诱导多能干细胞(iPSC)和 iPSC 衍生的肝细胞(iHeps)中的 Z 突变。我们证明,在患者 iPSC 中纠正 Z 突变可减少异常 AAT 的积累并增加其分泌。通过单细胞 RNA 测序,我们证明了分化的 iHeps 中的腺嘌呤碱基编辑(ABE)降低了编辑细胞中的内质网应激。我们发现 ABE 在 iPSC 中非常有效,并且通过全基因组测序未发现靶外基因组突变。这些结果揭示了碱基编辑纠正 AATD 患者细胞中 Z 突变的可行性和实用性。